Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
about
Oligodendrogenesis in the normal and pathological central nervous systemOligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and RepairOligodendroglial membrane dynamics in relation to myelin biogenesisExploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosisRemyelination Therapy in Multiple SclerosisThe lateral membrane organization and dynamics of myelin proteins PLP and MBP are dictated by distinct galactolipids and the extracellular matrixAstrocyte-derived tissue Transglutaminase affects fibronectin deposition, but not aggregation, during cuprizone-induced demyelinationMechanical Strain Promotes Oligodendrocyte Differentiation by Global Changes of Gene ExpressionAberrant production of tenascin-C in globoid cell leukodystrophy alters psychosine-induced microglial functionsThe role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.An Enzyme from Aristolochia indica Destabilizes Fibrin-β Amyloid Co-Aggregate: Implication in Cerebrovascular Diseases.Fibronectin Matrix Assembly after Spinal Cord InjuryA new in vitro mouse oligodendrocyte precursor cell migration assay reveals a role for integrin-linked kinase in cell motilityExtracellular matrix composition determines astrocyte responses to mechanical and inflammatory stimuliDemyelination as a rational therapeutic target for ischemic or traumatic brain injury.Modulation of oligodendrocyte differentiation and maturation by combined biochemical and mechanical cuesFibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build.The effect of glia-glia interactions on oligodendrocyte precursor cell biology during development and in demyelinating diseasesManipulating the extracellular matrix and its role in brain and spinal cord plasticity and repair.Astrocyte regulation of CNS inflammation and remyelination.From demyelination to remyelination: the road toward therapies for spinal cord injury.Role of autophagy in the pathogenesis of multiple sclerosis.Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.Myelin regulatory factor drives remyelination in multiple sclerosis.Extracellular cues influencing oligodendrocyte differentiation and (re)myelinationThe environment rules: spatiotemporal regulation of oligodendrocyte differentiation.Astrocytes in multiple sclerosis.Sulfatide-mediated control of extracellular matrix-dependent oligodendrocyte maturation.Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.Accumulation of Extracellular Matrix in Advanced Lesions of Canine Distemper Demyelinating Encephalitis.Inhibitors of myelination: ECM changes, CSPGs and PTPs.CD14 is a key organizer of microglial responses to CNS infection and injury.Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9.Sudan black: a fast, easy and non-toxic method to assess myelin repair in demyelinating diseases.The EIIIA domain from astrocyte-derived fibronectin mediates proliferation of oligodendrocyte progenitor cells following CNS demyelination.Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures.Achievements and obstacles of remyelinating therapies in multiple sclerosis.Oligodendrocyte Lineage Cells in Chronic Demyelination of Multiple Sclerosis Optic Nerve.The best basic science paper in MS in 2013: Antimuscarinic therapies in remyelination.
P2860
Q21129352-1E185087-CE5B-4780-8373-35C59401CB5FQ26739719-B94ACB2D-A927-42C8-90BD-CB6E77A727F6Q26753112-8523693F-362C-493B-BC6B-D8BE7E42B107Q26770818-BD8D1729-875D-48ED-A615-B11B34203CC6Q26772359-EB8077DC-C343-416D-BE49-D2A9EFDEC749Q28540508-2BE0BF44-4EFD-44BE-BC93-6091978F656EQ29248440-2E8A9172-7DD9-4229-8643-A9154E580871Q33581205-F4A06EB1-CF1F-41E0-A316-4E865913B0EAQ34214457-A75541C6-2587-454F-BA5D-922A17A702ACQ34468304-2D15757C-8AB2-4ADE-B51C-97DA56153ADFQ35609259-1287D35B-F1CD-4BD3-BAAD-8021CC609DAEQ35834455-3B95AC12-098C-4784-B631-B89612C86513Q35866061-81B492CC-3B3B-4AE1-9ECF-24D6DAB28E0EQ35910607-12BB6481-5B98-46E0-8239-CD202A88A579Q35933506-28595154-C71C-42DE-A350-C6B99734485FQ36090107-178CD466-D8CF-41A5-BA70-303772F846F5Q36583847-D47C1E43-36B1-407B-92B7-A4891DD5BA16Q38113681-43E2350C-2199-4F02-893C-4BC89BCBD773Q38175970-9EB56B0B-3D7D-49B3-96EE-DB499759CF29Q38179520-E7CD708D-0E7E-4D55-9DB8-D0750B0A9A04Q38222890-4CA8490F-B557-457D-A483-C44461CA00E0Q38366783-72E5FA1A-535C-4AE0-8306-B1FCBA6DA74EQ38562775-AD16A9ED-7FFC-4CD9-A2E2-AC2AF93BA049Q38616998-E1536D78-10AB-4139-B29D-F259825BAC0BQ38718081-4BEE900D-1A86-47C7-87B9-18CBEF763793Q38789322-3668EFF6-74AA-4AD7-A9A0-D8E0D9857020Q38820972-A62ACF80-FEB7-45D0-9BAC-9C6B380F0DC2Q38840390-5306C38E-0EC9-41D6-A116-6279866E8F60Q39020113-C23E319D-5711-424C-B749-2BF071A39818Q39146141-789E3276-3EE1-4D69-A3E4-8D468F551AB5Q39577135-FAE3E0BD-F717-4BB2-A9F6-2DE6CBEFF270Q40804371-9B644C3A-811F-45A8-A236-5B6832E7D300Q40865607-0AC875DC-D2C9-4C71-AD40-441844161117Q41020735-565CC979-7A4C-4111-992F-7F5F61948080Q41599503-52109E92-3E8A-420D-A4E3-A2A244690A1FQ42544806-09615C5C-7589-4BF2-A348-62EDA07F81F6Q47099586-65710038-5E54-4371-BC34-ECA3EAC11417Q47835493-9E6DF805-D1F4-49BD-BE43-EB422B820F05Q48572449-905612F9-7AB1-44AF-A7FF-D5A76D0ED903Q50446096-F1CF10D0-3080-4A4F-8A50-13EF60D358F4
P2860
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
@en
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
@nl
type
label
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
@en
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
@nl
prefLabel
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
@en
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
@nl
P2093
P2860
P356
P1433
P1476
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
@en
P2093
Anita Nomden
Charles Ffrench-Constant
Dick Hoekstra
Jenny C de Jonge
Josephine M J Stoffels
Miriam E van Strien
Mirjana Stancic
Olaf Maier
P2860
P304
P356
10.1093/BRAIN/AWS313
P407
P577
2013-01-01T00:00:00Z